RxDoctor Payments Data

Sooksai Kaewbua

Psychiatric/Mental Health · Mount Sterling, KYNPI 1366962599

Payments from drug & device makers

$3,896in general payments, 2019–2025

Across 140 payments — averaging $27.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$739
  • AbbVie$631
  • Neurocrine Biosciences, Inc.$595
  • Axsome Therapeutics, Inc.$542
  • Alkermes, Inc.$301
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$298
  • plus $791 from 18 others

What the payments were for

  • Food & beverage$3,84999%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,896 in reported general payments places this provider in the 85th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$97,044
Abilify MaintenaAripiprazole13$34,469
VraylarCariprazine Hcl24$34,450
AuvelityDextromethorphan Hbr/Bupropion12$23,606
Clozapine12$900
Duloxetine Hcl25$889
Amitriptyline Hcl11$728
Buspirone Hcl34$671
Bupropion XlBupropion Hcl32$616
Prazosin Hcl18$329
Trazodone Hcl46$275
Quetiapine Fumarate27$178
Hydroxyzine Pamoate14$177
Lamotrigine27$110
Sertraline Hcl11$109

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$595$97,04412 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$739$34,46913 claims
AbbVieVraylar$631$34,45024 claims
Axsome Therapeutics, Inc.Auvelity$542$23,60612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Mount Sterling

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →